• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

SidebySide: Investment Portfolio & Startup News

SidebySide

To add a bio or update investment portfolio click update information.

Investment Portfolio

    Tonic Health raises £2.8m Series A from Side by Side to tackle UK nutrient crisis and expand clean nutrition brandTonic Health raises £2.8m Series A from Side by Side to tackle UK nutrient crisis and expand clean nutrition brand
    Tonic Health
    1 Jul 2025

    Tonic Health raises £2.8m Series A from Side by Side to tackle UK nutrient crisis and expand clean nutrition brand

    Tonic Health produces clean, high-strength nutritional supplements designed to address widespread nutrient deficiencies, focusing on simple formulations without sugar or artificial additives at mass-market prices.

    Ryft raises £5.7m Series A led by EdenBase to equip acquirers with tech to rival Stripe and AdyenRyft raises £5.7m Series A led by EdenBase to equip acquirers with tech to rival Stripe and Adyen
    Ryft
    9 Apr 2025

    Ryft raises £5.7m Series A led by EdenBase to equip acquirers with tech to rival Stripe and Adyen

    Ryft provides compliant payment infrastructure for marketplaces and platforms, enabling acquiring banks and businesses to split, hold and route payments efficiently without building complex systems from scratch.

SidebySide
    • Consumer
    • Fintech
  • thesidebysidepartnership.com

More venture news

  • Boltz announces its £85m Series A round led by Bessemer Venture Partners to build AI models for molecular design
    Boltz
    18 Nov 2026

    Boltz announces its £85m Series A round led by Bessemer Venture Partners to build AI models for molecular design

    Series ALife Sciences
  • Zya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre
    Zya
    16 Nov 2026

    Zya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre

    Series AHealth
  • Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
    Oyster Therapeutics
    13 Nov 2026

    Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases

    Series ALife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn